Neuralink has announced that the U.S. Food and Han Yi-seul-I (한이슬) ArchivesDrug Administration (FDA) has approved the launch of its first clinical study in humans.
"We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!" Neuralink's official Twitter account wrote on Thursday. "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."
SEE ALSO: Elon Musk's Neuralink is reportedly under investigation for animal welfare violationsThe FDA confirmed Neuralink's announcement in a statement to Mashable.
"The FDA acknowledges and understands that Neuralink has announced that its investigational device exemption (IDE) for its implant/R1 robot was approved by the FDA and that it may now begin conducting human clinical trials for its device," said an FDA spokesperson.
R1 is a surgical robot designed to implant the neurotechnology company's brain chips.
Neuralink isn't recruiting test subjects just yet, and hasn't released any information on exactly what the clinical trial will involve. Even so, fans of Neuralink founder Elon Musk are already chomping at the bit to implant questionable experimental technology in their grey matter.
This Tweet is currently unavailable. It might be loading or has been removed.
Neuralink aims to develop implantable devices that will let people control computers with their brain, as well as restore vision or mobility to people with disabilities. However, while this may sound exciting for people with disabilities, there are serious concerns about Neuralink's brain chips.
The FDA reportedly rejected a previous application from Neuralink to begin human trials last year, as there were "dozens of issues the company must address." Among them were concerns that wires could shift and damage the brain, that the brain might be damaged during removal of the device, and that there may be potential issues with its lithium battery.
Neuralink is also currently under investigation for animal welfare violations, with reports of botched experiments resulting in needless suffering and death. This has allegedly included instances of surgeons using the wrong surgical tools, implanting Neuralink devices in incorrect locations, and implanting devices that were the wrong size.
Musk has spent years claiming that Neuralink would soon begin human trials. Now it looks as though it might finally actually happen.
UPDATE: May. 29, 2023, 11:09 a.m. AEST This article has been updated with comment from the U.S. Food and Drug Administration.
Topics Health Elon Musk
Tencent acquires two ByteDance gaming studios · TechNodeCCTV debuts AI anchors as part of Two Sessions coverage · TechNodeAlibaba Cloud cuts prices for international customers as AI demands rise · TechNodeJD shares surge after Q4 revenue beats expectations and flood of new users join · TechNodeAlibaba Cloud cuts prices for international customers as AI demands rise · TechNodeAMD's customized AI chip for Chinese market fails to secure US approval: report · TechNodeHonda launches ChinaTencent Cloud says recent service failure results from cloud API anomalies · TechNodeJD to invest $138 million into supporting short video content · TechNodeJack Ma praises Alibaba’s changes in the past year under new chairman and CEO · TechNodeGenshin Impact developer miHoYo makes debut in top 10 among global top 50 publishers · TechNodePDD’s Colin Huang becomes China’s secondMSI launches new Nvidia RTX 4090D graphics card for Chinese market · TechNodeVivo unveils X Fold3, the lightest and thinnest bookChina’s EHang partners with automaker GAC to develop flying cars · TechNodeBilibili overhauls main site operating unit as profitability timeline looms · TechNodeVolkswagen, BYD supplier Horizon Robotics files for Hong Kong IPO · TechNodeLi Auto launches its smallest plugChina’s EV price war escalating to “unsustainable” levels, says Bosch executive · TechNodeSony China refutes recent reports of smartphone withdrawal in China · TechNode Now Online: Our Interviews with Robert Caro and Luc Sante Poem: Kate Ellen Braverman’s “Classified Ad” Mahasweta Devi, 1926–2016 Looking for Artistic Success? This Allegorical Map Will Help Staff Picks: Wharton, Fermor, and Faking Your Own Death Staff Picks: Daniel Defoe, Laura Sims, Ann Quin, Evan Kindley Why Are There So Many Bars in My Novel? Figs Have All the Answers Prison Lit: Jones Very’s Words from the Asylum Unconventional, Part 3: Norman Mailer and the Pigs An Interview with ‘The Girls’ Author Emma Cline Ulysses S. Grant Repaired My Parents’ Dryer American Girl Night at the Saratoga Performing Arts Center Cool Struttin’ with Sonny Clark Jeff Koons’s Studio Squashes a Union How to Keep a Journal: The Bizarre Diary I Kept When I Was Sixteen Mourning the Unrealized Promise of Aerosolized Foods Dr. Seuss’s Midnight Paintings Zelda: A Worksheet What Sound Looks Like
1.1683s , 8225.9375 kb
Copyright © 2025 Powered by 【Han Yi-seul-I (한이슬) Archives】,Miracle Information Network